跳至主要内容
临床试验/NL-OMON48800
NL-OMON48800已完成不适用

Carotid Artery ImPlant for Trapping UpstReam Emboli <br>(CAPTURE) for Preventing Stroke in Atrial Fibrillation <br>Patients - CAPTURE

Javelin Medical Ltd.0 个研究点目标入组 2 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • 1. Atrial fibrillation (AF)
  • 2. CHA2DS2-VASc score >= 2
  • 3. Age > 50
  • 4. Unsuitable for oral anticoagulation therapy (OAC), defined as
  • contraindicated for OAC,
  • patient refusing OAC, or physician is reluctant to prescribe OAC
  • 5. Maximal (systolic) CCA diameter range: >= 4.8mm and <= 9.8mm
  • 6. CCA accessibility: up to 60mm from skin to CCA center, safe approach
  • 7. Patient is willing to provide informed consent
  • 8. Patient is willing to complete all scheduled follow-up

排除标准

  • 1. Evidence of carotid stenosis > 30% [CCA, internal carotid artery (ICA), or
  • external carotid artery (ECA)]
  • 2. Evidence of any atherosclerotic disease in CCA above the clavicles
  • 3. Evidence of carotid dissection
  • 4. Pre-existing stent(s) in CCA
  • 5. Contraindicated or allergic to antiplatelet therapy, or any medication
  • required during
  • 6. Recent stroke, TIA, or myocardial infarction (MI) within two months prior to
  • 7. Female who is pregnant or who is planning to become pregnant during the
  • 8. Life expectancy of less than 1 year
  • 9. Active systemic infection
  • 10. Known sensitivity to nickel or titanium metals, or their alloys
  • 11. Known hereditary or acquired coagulation disorders
  • 12. Any planned surgical or endovascular procedure within 14 days prior to or
  • after the index procedure
  • 13. A co-morbid disease or condition that could confound the neurological and
  • evaluations or compromise survival or ability to complete follow-up assessments
  • 14. Current use or a recent history of illicit drug(s) use or alcohol abuse
  • (defined as regular
  • or daily consumption of more than four alcoholic drinks per day)
  • 15. Active participation in another investigational drug or device treatment
  • 16. Any other condition that in the opinion of the investigator may adversely
  • safety of the subject or would limit the subject's ability to complete the

研究者

相似试验

Carotid Artery ImPlant for Trapping UpstReam Emboli... | 临床试验